ANI Pharmaceuticals Inc (ANIP)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	18,779	13,381	-5,159	-26,327	-47,896	-67,789	-63,636	-62,819	-42,603	-22,102	-17,221	-15,451	-22,548	-23,748	-20,287	-1,366	6,094	16,359	17,501	13,693
Revenue (ttm)	US$ in thousands	454,334	417,871	370,670	328,961	287,962	256,461	229,582	208,526	202,730	205,047	205,953	205,960	203,642	194,356	195,209	203,434	206,547	215,703	215,069	207,980
Net profit margin		4.13%	3.20%	-1.39%	-8.00%	-16.63%	-26.43%	-27.72%	-30.13%	-21.01%	-10.78%	-8.36%	-7.50%	-11.07%	-12.22%	-10.39%	-0.67%	2.95%	7.58%	8.14%	6.58%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $18,779K ÷ $454,334K
= 4.13%

The net profit margin of ANI Pharmaceuticals Inc has shown some fluctuation over the past eight quarters. In Q4 2023, the net profit margin stood at 3.52%, which indicates that the company retained 3.52% of its revenue as profit after all expenses were deducted. This represents an improvement from the previous quarter, Q3 2023, where the net profit margin was 2.46%.

However, looking further back, there was a significant decline in profitability in Q2 2023 and Q1 2023, with net profit margins of -1.87% and -7.82% respectively. This implies that the company incurred losses during these periods.

Comparing the current performance to the same quarter in the previous year, there has been a notable improvement. In Q4 2022, the net profit margin was -15.65%, signifying that the company was operating at a loss.

The trend indicates that ANI Pharmaceuticals Inc has been working towards improving its profitability, as reflected in the consecutive positive net profit margins in the recent quarters. However, the company should remain vigilant about managing its expenses and maximizing its revenue to sustain and further enhance its profitability in the future.